Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na+/K+-ATPase

Krenn, 1998, Bufadienolides from animal and plant sources, Phytochemistry, 48, 1, 10.1016/S0031-9422(97)00426-3 Prassas, 2008, Novel therapeutic applications of cardiac glycosides, Nat. Rev. Drug Discov., 7, 926, 10.1038/nrd2682 Moreno, 2013, Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase, Mol. Cancer, 12, 33, 10.1186/1476-4598-12-33 Bagrov, 2009, Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets, Pharmacol. Rev., 61, 9, 10.1124/pr.108.000711 Laursen, 2013, Crystal structure of the high-affinity Na+,K+-ATPase-ouabain complex with Mg2+ bound in the cation binding site, Proc. Natl. Acad. Sci. U. S. A., 110, 10958, 10.1073/pnas.1222308110 Blanco, 1998, Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function, Am. J. Physiol. Renal, 275, F633, 10.1152/ajprenal.1998.275.5.F633 Dostanic-Larson, 2006, Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site, Am. J. Physiol. Regul. Integr. Comp. Physiol., 290, R524, 10.1152/ajpregu.00838.2005 Lingrel, 2007, Na,K-ATPase and the role of alpha isoforms in behavior, J. Bioenerg. Biomembr., 39, 385, 10.1007/s10863-007-9107-9 Yang, 2009, Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targets, Mol. Cancer Ther., 8, 2319, 10.1158/1535-7163.MCT-08-1085 Wang, 2001, All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides, Am. J. Physiol. Cell Physiol., 281, C1336, 10.1152/ajpcell.2001.281.4.C1336 Müller-Ehmsen, 2001, Ouabain and substrate affinities of human Na(+)-K(+)-ATPase alpha(1) beta(1), alpha(2) beta(1), and alpha(3) beta(1) when expressed separately in yeast cells, Am. J. Physiol. Cell Physiol., 281, C1355, 10.1152/ajpcell.2001.281.4.C1355 Shamraj, 1993, Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts, Cardiovasc. Res., 27, 2229, 10.1093/cvr/27.12.2229 Liang, 2007, Identification of a pool of non-pumping Na/K-ATPase, J. Biol. Chem., 282, 10585, 10.1074/jbc.M609181200 Wang, 2004, Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase, J. Biol. Chem., 79, 17250, 10.1074/jbc.M313239200 Liu, 2000, Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations, J. Biol. Chem., 275, 27838, 10.1074/jbc.M002950200 Nguyen, 2011, Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation, Am. J. Physiol. Renal Physiol., 301, F897, 10.1152/ajprenal.00095.2011 Newman, 2008, Cardiac glycosides as novel cancer therapeutic agents, Mol. Interv., 8, 36, 10.1124/mi.8.1.8 Li, 2009, PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells, Anticancer Drugs, 20, 59, 10.1097/CAD.0b013e3283160fd6 Mijatovic, 2012, Cardiotonic steroids-mediated targeting of the Na(+)/K(+)-ATPase to combat chemoresistant cancers, Curr. Med. Chem., 19, 627, 10.2174/092986712798992075 Mijatovic, 2006, The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells, Mol. Cancer Ther., 5, 391, 10.1158/1535-7163.MCT-05-0367 Yuan, 2005, Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex, Mol. Biol. Cell, 16, 4034, 10.1091/mbc.E05-04-0295 Pierre, 2006, The Na,K-ATPase receptor complex: its organization and membership, Cell Biochem. Biophys., 46, 303, 10.1385/CBB:46:3:303 Ameyar, 2003, A role for AP-1 in apoptosis: the case for and against, Biochimie, 85, 747, 10.1016/j.biochi.2003.09.006 Takeuchi, 2006, Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent, FEBS J., 273, 3743, 10.1111/j.1742-4658.2006.05377.x Liu, 2010, The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking, Biochim. Biophys. Acta, 1802, 1237, 10.1016/j.bbadis.2010.01.013 Kometiani, 2005, Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells, Mol. Pharmacol., 67, 929, 10.1124/mol.104.007302 Mijatovic, 2013, Cardiotonic steroids-mediated Na+/K+-ATPase targeting could circumvent various chemoresistance pathways, Planta Med., 79, 189 Simpson, 2009, Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation, Cancer Res., 69, 2739, 10.1158/0008-5472.CAN-08-2530 Moreno, 2013, Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells, J. Nat. Prod., 76, 1078, 10.1021/np400034d Nooter, 1994, Clinical relevance of P-glycoprotein expression in haematological malignancies, Leuk. Res., 18, 233, 10.1016/0145-2126(94)90025-6 Marie, 1999, MDR1/P-GP expression as a prognostic factor in acute leukemias, Adv. Exp. Med. Biol., 457, 1, 10.1007/978-1-4615-4811-9_1 Wuchter, 2000, Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia, Haematologica, 85, 711 Steinbach, 2007, ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?, Leukemia, 21, 1172, 10.1038/sj.leu.2404692 Pirker, 1991, MDR1 gene expression and treatment outcome in acute myeloid leukemia, J. Natl. Cancer Inst., 83, 708, 10.1093/jnci/83.10.708 Pui, 2009, Acute lymphoblastic leukemia: introduction, Semin. Hematol., 46, 1, 10.1053/j.seminhematol.2008.09.011 Foley, 1965, Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia, Cancer, 18, 522, 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J Kimmig, 1990, Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells, Cancer Res., 50, 6793 Akiyama, 1985, Isolation and genetic characterization of human KB cell lines resistant to multiple drugs, Somat. Cell Mol. Genet., 11, 117, 10.1007/BF01534700 Zeino, 2015, Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids, Biochem. Pharmacol., 93, 11, 10.1016/j.bcp.2014.10.009 Hauswald, 2009, Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes, Clin. Cancer Res., 15, 3705, 10.1158/1078-0432.CCR-08-2048 Cherkasov, 2014, QSAR modeling: where have you been? Where are you going to?, J. Med. Chem., 57, 4977, 10.1021/jm4004285 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Garlid, 2003, Mitochondrial potassium transport: the K(+) cycle, Biochim. Biophys. Acta, 1606, 23, 10.1016/S0005-2728(03)00108-7 Andersson, 2006, Induction of apoptosis by intracellular potassium ion depletion: using the fluorescent dye PBFI in a 96-well plate method in cultured lung cancer cells, Toxicol. In Vitro, 20, 986, 10.1016/j.tiv.2005.12.013 Jezek, 1990, Reconstitution of the beef heart and rat liver mitochondrial K+/H+ (Na+/H+) antiporter. Quantitation of K+ transport with the novel fluorescent probe, PBFI, J. Biol. Chem., 265, 10522, 10.1016/S0021-9258(18)86978-2 R.E. Kingston, Preparation of poly(A)+ RNA, Curr. Protoc. Mol. Biol., 2001 (Chapter 4), Unit 4.5. Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nat. Methods, 5, 621, 10.1038/nmeth.1226 Hall, 2009, Is resistance useless? Multidrug resistance and collateral sensitivity, Trends Pharmacol. Sci., 30, 546, 10.1016/j.tips.2009.07.003 Banuls, 2013, Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells, J. Nat. Prod., 76, 1078, 10.1021/np400034d Johansson, 2001, Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells, Anticancer Drugs, 12, 475, 10.1097/00001813-200106000-00009 Wallace, 1995, LIGPLOT: a program to generate schematic diagrams of protein–ligand interactions, Protein Eng., 8, 127, 10.1093/protein/8.2.127 Mahringer, 2010, Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine, Cancer Genom. Proteom., 7, 191 Chen, 2000, Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest, J. Natl. Cancer Inst., 92, 1999, 10.1093/jnci/92.24.1999 Saeed, 2013, Collateral sensitivity in drug-resistant tumor cells, 187 Laberge, 2009, P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil, Arch. Biochem. Biophys., 491, 53, 10.1016/j.abb.2009.09.012 Sharom, 1997, The P-glycoprotein efflux pump: how does it transport drugs?, J. Membr. Biol., 160, 161, 10.1007/s002329900305 Chen, 2010, Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+-ATPase, Acta Pharmacol. Sin., 31, 696, 10.1038/aps.2010.61 Kamano, 2002, QSAR evaluation of the Ch’an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1), J. Med. Chem., 45, 5440, 10.1021/jm0202066 Ishihara, 2009, Estimation of relationship between descriptors and cytotoxicity of newly synthesized 1,2,3,4-tetrahydroisoquinoline derivatives, Anticancer Res., 29, 4077 Wise, 2012, Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites, Biochemistry, 51, 5125, 10.1021/bi300299z Zeino, 2014, The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein-a well-known, yet poorly understood drug transporter, Invest. New Drugs, 10.1007/s10637-014-0098-1 Sagné, 1996, SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter, Biochem. J., 316, 825, 10.1042/bj3160825 Zhao, 2013, Transmembrane protein 208: a novel ER-localized protein that regulates autophagy and ER stress, PLoS One, 8, e64228, 10.1371/journal.pone.0064228 McLane, 2007, Heating induces aggregation and decreases detection of serotonin transporter protein on western blots, Synapse, 61, 875, 10.1002/syn.20438 Beck, 1986, Differentiation and the multiple drug resistance phenotype in human leukemic cells, Cancer Res., 46, 4571 Biedler, 1975, Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells, J. Natl. Cancer Inst., 55, 671, 10.1093/jnci/55.3.671 Karitskaya, 2010, Long-term regulation of Na,K-ATPase pump during T-cell proliferation, Pflug. Arch., 460, 777, 10.1007/s00424-010-0843-z Bose, 1988, Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line, Cancer Chemother. Pharmacol., 21, 14, 10.1007/BF00262731 Stordal, 2012, Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein, PLoS One, 7, e40717, 10.1371/journal.pone.0040717 Evdokimova, 2009, Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1, Cell Cycle, 8, 2901, 10.4161/cc.8.18.9537 Howland, 2006 Tian, 2009, Changes in sodium pump expression dictate the effects of ouabain on cell growth, J. Biol. Chem., 284, 14921, 10.1074/jbc.M808355200 Chan, 2013, Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na+/K+-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades, Biochem. Pharmacol., 86, 1564, 10.1016/j.bcp.2013.09.021 Li, 2011, Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin, Oncol. Rep., 25, 825 Hawkins, 2010, Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor, J. Neurosci., 30, 1417, 10.1523/JNEUROSCI.5103-09.2010 Lefranc, 2008, The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas, Neoplasia, 10, 198, 10.1593/neo.07928 Liu, 2015, The upregulation of PI3K/Akt and MAP kinase pathways is associated with resistance of microtubule-targeting drugs in prostate cancer, J. Cell. Biochem., 10.1002/jcb.25091 Seres, 2008, Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity, Gen. Physiol. Biophys., 27, 211 Mestdagh, 1994, Comparative study of intracellular calcium and adenosine 3′,5′-cyclic monophosphate levels in human breast carcinoma cells sensitive or resistant to Adriamycin: contribution to reversion of chemoresistance, Biochem. Pharmacol., 48, 709, 10.1016/0006-2952(94)90048-5 Tsuruo, 1984, High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells, Cancer Res., 44, 5095 Foskett, 2007, Inositol trisphosphate receptor Ca2+ release channels, Physiol. Rev., 87, 593, 10.1152/physrev.00035.2006 Galuska, 2011, C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells, PLoS One, 6, e28294, 10.1371/journal.pone.0028294 Chibalin, 1998, Phosphorylation of the catalyic alpha-subunit constitutes a triggering signal for Na+,K+-ATPase endocytosis, J. Biol. Chem., 273, 8814, 10.1074/jbc.273.15.8814 Liang, 1999, Nitric oxide activates PKCalpha and inhibits Na+-K+-ATPase in opossum kidney cells, Am. J. Physiol., 277, F859 Cerella, 2013, Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides, Mitochondrion, 13, 225, 10.1016/j.mito.2012.06.003 Johnstone, 2000, Multiple physiological functions for multidrug transporter P-glycoprotein?, Trends Biochem. Sci., 25, 1, 10.1016/S0968-0004(99)01493-0 Young, 2011, Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression, Int. J. Biochem. Mol. Biol., 2, 219 Boscoboinik, 1990, Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells, Br. J. Cancer, 61, 568, 10.1038/bjc.1990.127 Winnicka, 2008, Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells, Biol. Pharm. Bull., 31, 1131, 10.1248/bpb.31.1131 Huang, 2013, Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells, PLoS One, 8, e66130, 10.1371/journal.pone.0066130 Wang, 2014, Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1, Cancer Res., 74, 1506, 10.1158/0008-5472.CAN-13-2939 Sun, 2011, Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 cells, Evid. Based Complement. Alternat. Med. eCAM, 2011, 249090, 10.1093/ecam/nep082